Patents Assigned to ESTABLISSEMENT FRANCAIS DU SANG
  • Attenuated strain of pseudomonas as a vaccine for pseudomonas infection
    Patent number: 11045539
    Abstract: The present disclosure is related to a live-attenuated strain of Pseudomonas for its use as a vaccine, and for use in a method for preventive immunizing and for treating Pseudomonas infection, in particular in patients suffering from cystic fibrosis. Preferably, the live-attenuated strain of Pseudomonas is furthermore treated to become ‘killed but metabolically active’.
    Type: Grant
    Filed: February 15, 2018
    Date of Patent: June 29, 2021
    Assignees: Universite Grenoble Alpes, Centre Hospitalier Universitaire Grenoble Alpes, Establissement Francais Du Sang
    Inventors: Audrey Le Gouellec, Bertrand Toussaint, Jean-Luc Lenormand, David Laurin, Elodie Meynet
  • ZEODRATION METHOD FOR THE PRESERVATION OF BLOOD PLATELETS
    Publication number: 20130078608
    Abstract: The present invention relates to a new method for the preservation of blood platelets. In particular, the present invention provides a method which includes submitting the platelets to zeodration carried out at temperatures between 18° C. and 24° C. The dried platelets thus obtained can be preserved at room temperature for long period of time. The invention also provides kits and compositions for using the preserved platelets.
    Type: Application
    Filed: November 26, 2010
    Publication date: March 28, 2013
    Applicant: ESTABLISSEMENT FRANCAIS DU SANG
    Inventors: Francine Rendu, Thibault Donnet, Christian Gachet, Jean-Pierre Cazenave